Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Feb 2024 for CERO THERAPEUTICS HOLDINGS, INC.. Read the official filing
Filing timeline
BuySaleDaniel E. Geffken
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Daniel E. Geffken: trading record in brief
Filings by Daniel E. Geffken span 3 companies, the busiest being Windtree Therapeutics Inc, Cero Therapeutics Holdings, Inc. and Eloxx Pharmaceuticals, Inc. Over a trading history stretching from 29 November 2021 to 14 February 2024, the count stands at 4 filings.
No open-market sale appears; the market trades are 1 purchase worth €32k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants.
The newest entry dates from 16 February 2024: a transaction, in Cero Therapeutics Holdings, Inc. The clock since the last published purchase (1 December 2021) now reads 1,782 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel E. Geffken
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
10,002 sharesClass A Common StockSEC:0001213900-24-015030:0
2,033 shares0Common StockSEC:0001437749-23-024844:0
5,000 shares0Common StockSEC:0001437749-22-014714:0
50,000 shares@ US$0.72100.0% of flowCommon StockSEC:0001415889-21-005600:0
Canonical exit: 27 Feb 2022 (T+90)
4 of 4 declarations
